← Eichor
Condition: Heterozygous Familial Hypercholesterolemia Hefh Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Heterozygous Familial Hypercholesterolemia Hefh

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION
Phase 3 · 52 location(s) · Novartis Pharmaceuticals · NCT05682378
Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozyg
Phase N/A · 3 location(s) · Nantes University Hospital · NCT06634160
The ORIGIN-FH Study
NA · 1 location(s) · University of Wisconsin, Madison · NCT07470723
A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familia
Phase 2/Phase 3 · 36 location(s) · Merck Sharp & Dohme LLC · NCT07058077
"Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"
NA · 3 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07427472
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Phase 3 · 66 location(s) · Novartis Pharmaceuticals · NCT06597019
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Phase 1 · 19 location(s) · CRISPR Therapeutics AG · NCT07491172
A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
Phase 3 · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07465263
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.